Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Study Overview: Bayer AG is conducting a Phase 3 study titled A ...

Seastar Medical Holding Corporation (($ICU)) announced an update on their ongoing clinical study. Seastar Medical Holding Corporation (ICU) is ...

A new clinical practice guideline developed by a task force of the American Academy of Sleep Medicine provides updated ...

A new clinical practice guideline developed by a task force of the American Academy of Sleep Medicine provides updated ...

Recently a relative faced a harrowing differential diagnosis: The fluid in his lungs could be cancerous. We were all worried.

SGLT2 inhibitors represent one of the most remarkable therapeutic developments in heart failure care, transitioning from ...

About eight million people in the UK take some sort of antidepressant for mental health conditions such as depression and ...

A new experimental therapy helps restore the heart’s flexibility in models of stiffened heart failure. Michael Gotthardt and his colleagues at the Max Delbrück Center are working with U.S. researchers ...

The PREVENT tool — the newest cardiovascular risk calculator — makes individual dialogue between doctor and patient more ...

Cardiac performance in patients with HF can be determined with measurement of the time for peak oxygen uptake to decrease by more than 12.5%.

Real-world data reinforce SGLT2 inhibitors as first-line therapy for frail, older adults with heart failure with preserved ...

A landmark study led by University experts has shown that artificial intelligence can better predict how doctors should treat ...